8.30
price down icon3.94%   -0.34
after-market Dopo l'orario di chiusura: 8.29 -0.01 -0.12%
loading

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

pulisher
05:54 AM

CAPRICOR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

05:54 AM
pulisher
12:22 PM

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - NewMediaWire

12:22 PM
pulisher
10:30 AM

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE - GlobeNewswire

10:30 AM
pulisher
10:28 AM

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire

10:28 AM
pulisher
10:09 AM

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire

10:09 AM
pulisher
08:22 AM

Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action - PR Newswire

08:22 AM
pulisher
Sep 09, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - pmg-ky3.com

Sep 09, 2026
pulisher
Sep 09, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire

Sep 09, 2026
pulisher
Sep 09, 2026

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - FinancialContent

Sep 09, 2026
pulisher
Sep 09, 2026

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - natlawreview.com

Sep 09, 2026
pulisher
Sep 09, 2026

Deadline Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire

Sep 09, 2026
pulisher
Sep 09, 2026

Bronstein, Gewirtz & Grossman LLC Urges Capricor - GlobeNewswire

Sep 09, 2026
pulisher
Sep 09, 2026

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therapeutics, Inc. LawsuitCAPR - PR Newswire

Sep 09, 2026
pulisher
Sep 09, 2026

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Sep 09, 2026
pulisher
Sep 09, 2026

CAPR Legal Notice: BFA Law Notifies Capricor Therapeutics Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline - GlobeNewswire Inc.

Sep 09, 2026
pulisher
Sep 08, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 - GlobeNewswire

Sep 08, 2026
pulisher
Sep 08, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire

Sep 08, 2026
pulisher
Sep 08, 2026

GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits

Sep 08, 2026
pulisher
Sep 08, 2026

Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire

Sep 08, 2026
pulisher
Sep 08, 2026

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action DeadlineContact the Firm Before September 28, 2026 - NewMediaWire

Sep 08, 2026
pulisher
Sep 08, 2026

CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 08, 2026
pulisher
Sep 08, 2026

CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Sep 08, 2026
pulisher
Sep 08, 2026

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 28, 2026 DeadlineRGRD Law - marketscreener.com

Sep 08, 2026
pulisher
Sep 08, 2026

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. - GlobeNewswire

Sep 08, 2026
pulisher
Sep 08, 2026

CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT - GlobeNewswire

Sep 08, 2026
pulisher
Sep 08, 2026

CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure - PR Newswire

Sep 08, 2026
pulisher
Sep 07, 2026

CAPR DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 07, 2026
pulisher
Sep 07, 2026

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Datavault AI Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 07, 2026
pulisher
Sep 07, 2026

CAPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ca - The National Law Review

Sep 07, 2026
pulisher
Sep 07, 2026

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline - PR Newswire

Sep 07, 2026
pulisher
Sep 06, 2026

CAPR FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionCAPR - ACCESS Newswire

Sep 06, 2026
pulisher
Sep 06, 2026

2026-09-06 | CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:CAPR | Press Release - stockhouse.com

Sep 06, 2026
pulisher
Sep 06, 2026

CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Caprico - The National Law Review

Sep 06, 2026
pulisher
Sep 04, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc.CAPR - PR Newswire

Sep 04, 2026
pulisher
Sep 04, 2026

Could New Long-Term Data Support Capricor’s Duchenne Therapy? - Yahoo Finance

Sep 04, 2026
pulisher
Sep 04, 2026

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026 - FinancialContent

Sep 04, 2026
pulisher
Sep 04, 2026

CAPR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire

Sep 04, 2026
pulisher
Sep 04, 2026

CAPRCapricor Therapeutics Inc Options - Finviz

Sep 04, 2026
pulisher
Sep 04, 2026

Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Sep 04, 2026
pulisher
Sep 04, 2026

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline - TMX Newsfile

Sep 04, 2026
pulisher
Sep 04, 2026

Capricor Therapeutics (CAPR) Borrow Rates Rise Amidst Unprofitab - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

CAPR Stock Drop: Capricor Therapeutics Faces Securities - globenewswire.com

Sep 04, 2026
pulisher
Sep 03, 2026

Capricor: Downgrade to Hold On Deramiocel PDUFA Extension And DMD Change (NASDAQ:CAPR) - Seeking Alpha

Sep 03, 2026
pulisher
Sep 03, 2026

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 03, 2026
pulisher
Sep 03, 2026

CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action NoticeContact SueWallSt - Morningstar

Sep 03, 2026
pulisher
Sep 03, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire

Sep 03, 2026
pulisher
Sep 03, 2026

Kaplan Fox Deadline Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Have Until September 28, 2026 to Seek a Lead Plaintiff Role - NewMediaWire

Sep 03, 2026
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):